EVOLUTIONARY GENOMICS, INC. Quarterly Assets in USD from Q4 2010 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Evolutionary Genomics, Inc. quarterly Assets history and growth rate from Q4 2010 to Q4 2022.
Evolutionary Genomics, Inc. Assets for the quarter ending December 31, 2022 was $2.35M, a 19.7% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2022	$2.35M	-$578K	-19.7%	Dec 31, 2022	10-K	2023-03-09
Q3 2022	$2.69M	-$878K	-24.6%	Sep 30, 2022	10-Q	2022-10-21
Q2 2022	$3.09M	-$148K	-4.57%	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$3.5M	-$106K	-2.94%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$2.93M	-$1.06M	-26.6%	Dec 31, 2021	10-K	2023-03-09
Q3 2021	$3.57M	-$890K	-20%	Sep 30, 2021	10-Q	2021-11-01
Q2 2021	$3.24M	-$933K	-22.4%	Jun 30, 2021	10-Q	2021-08-06
Q1 2021	$3.61M	-$559K	-13.4%	Mar 31, 2021	10-Q	2021-05-13
Q4 2020	$3.99M	-$250K	-5.89%	Dec 31, 2020	10-K	2022-03-22
Q3 2020	$4.46M	+$24.7K	+0.56%	Sep 30, 2020	10-Q	2020-11-13
Q2 2020	$4.17M	-$419K	-9.13%	Jun 30, 2020	10-Q	2020-08-19
Q1 2020	$4.17M	-$92K	-2.16%	Mar 31, 2020	10-Q	2020-05-12
Q4 2019	$4.24M	-$146K	-3.33%	Dec 31, 2019	10-K	2021-03-31
Q3 2019	$4.43M	-$119K	-2.62%	Sep 30, 2019	10-Q	2019-10-17
Q2 2019	$4.59M	-$203K	-4.24%	Jun 30, 2019	10-Q	2019-08-12
Q1 2019	$4.26M	-$872K	-17%	Mar 31, 2019	10-Q	2019-05-15
Q4 2018	$4.39M	-$1.01M	-18.7%	Dec 31, 2018	10-K	2020-03-30
Q3 2018	$4.55M	-$852K	-15.8%	Sep 30, 2018	10-Q	2018-11-14
Q2 2018	$4.79M	-$832K	-14.8%	Jun 30, 2018	10-Q	2018-07-27
Q1 2018	$5.13M	-$957K	-15.7%	Mar 31, 2018	10-Q	2018-05-15
Q4 2017	$5.4M	-$1M	-15.7%	Dec 31, 2017	10-K	2019-04-01
Q3 2017	$5.4M	+$218K	+4.21%	Sep 30, 2017	10-Q	2017-11-13
Q2 2017	$5.62M	+$297K	+5.58%	Jun 30, 2017	10-Q	2017-08-03
Q1 2017	$6.09M	+$459K	+8.15%	Mar 31, 2017	10-Q	2017-05-11
Q4 2016	$6.4M	+$3.23M	+102%	Dec 31, 2016	10-K	2018-03-05
Q3 2016	$5.18M	+$5.18M		Sep 30, 2016	10-Q	2016-11-04
Q2 2016	$5.33M	+$5.32M	+70935%	Jun 30, 2016	10-Q	2016-08-12
Q1 2016	$5.63M	+$5.62M	+56216%	Mar 31, 2016	10-Q	2016-05-11
Q4 2015	$3.17M	+$1.81M	+133%	Dec 31, 2015	10-K	2017-02-10
Q3 2015	$5K^*	+$4.88K		Sep 30, 2015	10-Q	2015-10-06
Q2 2015	$7.5K	+$6.67K		Jun 30, 2015	10-Q	2015-08-04
Q1 2015	$10K	+$9.23K		Mar 31, 2015	10-Q	2015-05-14
Q4 2014	$1.36M	+$1.36M		Dec 31, 2014	10-K	2016-02-19
Q3 2014	$120^*	-$496		Sep 30, 2014	10-Q	2014-11-14
Q2 2014	$831^*	-$117		Jun 30, 2014	10-Q	2014-08-19
Q1 2014	$771^*	+$382		Mar 31, 2014	10-Q	2014-05-12
Q4 2013	$991^*	+$340		Dec 31, 2013	10-K	2015-03-05
Q3 2013	$616^*	+$457		Sep 30, 2013	10-Q	2013-11-13
Q2 2013	$948^*	+$759		Jun 30, 2013	10-Q	2013-08-19
Q1 2013	$389^*	+$96.00		Mar 31, 2013	10-Q	2013-05-20
Q4 2012	$651^*	+$287		Dec 31, 2012	10-K	2014-04-16
Q3 2012	$159^*	+$69.00		Sep 30, 2012	10-Q	2012-11-13
Q2 2012	$189^*	-$12		Jun 30, 2012	10-Q	2012-08-14
Q1 2012	$293^*			Mar 31, 2012	10-Q	2012-05-15
Q4 2011	$364^*	-$1		Dec 31, 2011	10-K	2013-04-15
Q3 2011	$90.00^*			Sep 30, 2011	10-Q	2011-11-18
Q2 2011	$201^*			Jun 30, 2011	10-Q/A	2011-08-17
Q4 2010	$365^*			Dec 31, 2010	10-K/A	2012-04-24

* An asterisk sign (*) next to the value indicates that the value is likely invalid.